Wall Street’s Top Analysts Upgrades, Downgrades & Initiations
$BLK, $BMY, $LVTL, $NVDA, $MON, $FOXA
Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of Wall Streets top analysts upgrades, downgrades and initiations for Tuesday, as follows:
BlackRock Inc. (NYSE:BLK) maintained as Buy at Goldman Sachs, but the firm removed it from the prized Conviction Buy list. Its price target was moved to 400 from 390. BlackRock has a 52-wk trading range of 275.00 – 375.26.
Bristol-Myers Squibb Co. (NYSE:BMY) analysts downgraded to Neutral from Outperform with a 63 price target at Credit Suisse. This is after the big drug disappointment sent shares down almost 16% Friday and another 4.71% Monday for a close at 60.30. The 52-wk range is 51.82 – 77.12.
Level 3 Communications Inc. (NYSE:LVLT) started with a Buy rating and assigned a 63 price target at BTIG. It has a consensus analyst price target of 60.67 and a 52-wk trading range of 40.86 – 57.59.
NVIDIA Corp. (NASDAQ:NVDA) analysts reiterated as Buy and the price target was raised to 69 from 56 at Jefferies. This call is ahead of earnings, and Jefferies thinks NVIDIA products have momentum and that there is high probability for more upside surprises over the next 6 to 18 months.
Monsanto Co. (NYSE:MON) analysts raised to Buy from Neutral at Monness Crespi Hardt. Shares closed at 106.75 Monday, Vs a consensus price target of 112.71 and in a 52-week range of 106.48 – 107.48.
Twenty-First Century Fox Inc. (NASDAQ:FOXA) downgraded to Equal Weight from Overweight and the price target was cut to 29 from 33 at Barclays
Latest posts by Paul Ebeling (see all)
- The New Ferrari (NYSE:RACE) Challenge Racer is the Fastest Ever - December 6, 2016
- Getting a Good Night’s Sleep w/o Rx Drugs - December 6, 2016
- The World’s Top 100 Restaurants Includes 100 in China - December 6, 2016